Melissa Bersanelli, Alessio Cortellini, & Sebastiano Buti. (2021). The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: Shifting the concept from the "inflamed tumor" to the "inflamed patient". Taylor & Francis Group.
Chicago Style (17th ed.) CitationMelissa Bersanelli, Alessio Cortellini, and Sebastiano Buti. The Interplay Between Cholesterol (and Other Metabolic Conditions) and Immune-checkpoint Immunotherapy: Shifting the Concept from the "Inflamed Tumor" to the "Inflamed Patient". Taylor & Francis Group, 2021.
MLA (9th ed.) CitationMelissa Bersanelli, et al. The Interplay Between Cholesterol (and Other Metabolic Conditions) and Immune-checkpoint Immunotherapy: Shifting the Concept from the "Inflamed Tumor" to the "Inflamed Patient". Taylor & Francis Group, 2021.